Security key
128058302
LISATA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (LSTA)
CUSIP: 128058302
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 1,089,429
- Total 13F value
- $3,704,050
- Share change
- +43,941
- SEC-reported price per share
- $3.40
- Number of holders
- 30
- Value change
- -$169,884
- Number of buys
- 12
- Number of sells
- 10
- Shares outstanding
- 9,061,739
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
30
Top holders
10
LSTA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
LISATA THERAPEUTICS, INC. SEC filings
LISATA THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 128058302
Recent filing periods:
Ownership snapshot
Top reported holders of LSTA - LISATA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Mohammad Azab
Disclosed value leader
VANGUARD CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
Mohammad Azab leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Mohammad Azab's linked filing trail.
Comparable ownership
Top 5
Mohammad Azab
1.2%
Steven M. Klosk
1.1%
Gregory B. Brown
1.1%
Cynthia Louise Flowers
1.1%
Heidi Henson
0.95%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Mohammad Azab |
3/4/5
Director
|
1.2%
|
$246,573
104,925 shares
|
— | 09 Jan 2026 |
| Steven M. Klosk |
3/4/5
Director
|
1.1%
|
$225,165
95,815 shares
|
— | 09 Jan 2026 |
| Gregory B. Brown |
3/4/5
Director
|
1.1%
|
$224,798
95,659 shares
|
— | 09 Jan 2026 |
| Cynthia Louise Flowers |
3/4/5
Director
|
1.1%
|
$224,298
95,446 shares
|
— | 09 Jan 2026 |
| Heidi Henson |
3/4/5
Director
|
0.95%
|
$201,453
85,725 shares
|
— | 09 Jan 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3%
|
$1,361,793
271,815 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
1,089,429
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
33
Q2 2026 holders
30
Holder diff
-3
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend